AitkenDA, CrossleyJA, SpencerK, Prenatal screening for neural tube defects and aneuploidy. In: Emery and Rimoin’s Principles and Practice of Medical Genetics, 5th edn., RimoinDL, ConnorJM, PyeritzRE, KorfBR (eds), Churchill Livingstone: Edinburgh, 2007.
AntoniouA, PharoahPD, NarodS, et al., Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies, Am J Hum Genet, 2003;72:1117–30.
AntoniouAC, RookusM, AndrieuN, et al., Reproductive and hormonal factors, and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers: results from the International BRCA1/2 Carrier Cohort Study, Cancer Epidemiol Biomarkers Prev, 2009;18:601–10.
ChiuRW, AkolekarR, ZhengYW, et al., Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study, BMJ, 2011;342:c7401.
DasheJS, TwicklerDM, Santos-RamosR, et al., Alpha-fetoprotein detection of neural tube defects and the impact of standard ultrasound, Am J Obstet Gynecol, 2006;195:1623–8.
Emery and Rimoin’s Principles and Practice of Medical Genetics.
6th edn., Elsevier: London,
2013; online edition at
www.sciencedirect.com.
FullertonG, HamiltonM, MaheshwariA, Should non-mosaic Klinefelter syndrome men be labelled as infertile in 2009?, Hum Reprod, 2010;25:588–97.
HarperPS, Practical Genetic Counselling, 7th edn., Hodder Arnold: London, 2010.
SouthernKW, MérelleMM, Dankert-RoelseJE, NagelkerkeAD, Newborn screening for cystic fibrosis, Cochrane Database Syst Rev, 2009;CD001402.
TobiasES, ConnorM, Ferguson-SmithM, Essential Medical Genetics, 6th edn., Singapore: Wiley-Blackwell, 2011.